Sunmed Disposable Angio-Closure Pads

K191827 · Sunny Medical Device (Shenzhen) Co., Ltd. · DXC · Mar 16, 2020 · Cardiovascular

Device Facts

• Record ID: K191827
• Device Name: Sunmed Disposable Angio-Closure Pads
• Applicant: Sunny Medical Device (Shenzhen) Co., Ltd.
• Product Code: DXC · Cardiovascular
• Decision Date: Mar 16, 2020
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.4450
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Sunmed™ disposable angio-closure pads is to assist in obtaining and maintaining hemnostasis.

Device Story

Sunmed disposable angio-closure pads consist of a medical polyurethane compression bulb, medical adhesive tape compression band, and medical polycarbonate infusion mouth. Device is used to assist in obtaining and maintaining hemostasis at vascular access sites. Operated by clinicians in a clinical setting. Device provides mechanical compression to the puncture site to facilitate blood clotting. Benefits include effective management of post-procedural vascular access sites.

Clinical Evidence

No clinical data. Evidence consists of non-clinical bench testing, including biocompatibility (pyrogen, acute systemic toxicity, skin sensitization, intracutaneous reactivity, in vitro cytotoxicity, bacterial endotoxins), package penetration, asepsis, aging, and EtO/ECH residue testing.

Technological Characteristics

Materials: medical polyurethane (compression bulb), medical adhesive tape (compression band), medical polycarbonate (infusion mouth). Mechanical compression principle. Sterile, single-use device. No software or electronic components.

Indications for Use

Indicated for assisting in obtaining and maintaining hemostasis in patients requiring vascular closure.

Regulatory Classification

Identification

A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.

Predicate Devices

• Safeguard™ 24cm pressure assisted dressing (K062569)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

March 16, 2020

Sunny Medical Device (Shenzhen) Co.,Ltd. James Zhang General Manager 56 Lehigh Aisle Irvine, California 92612

Re: K191827

Trade/Device Name: SunmedTM Disposable Angio-Closure Pads Regulation Number: 21 CFR 870.4450 Regulation Name: Vascular Clamp Regulatory Class: Class II Product Code: DXC Dated: July 8, 2019 Received: July 8, 2019

Dear James Zhang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Rachel Neubrander, Ph.D. Assistant Director DHT2B: Division of Circulatory Support, Structural and Vascular Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K191827

#### Device Name

Sunmed disposable angio-closure pads

Indications for Use (Describe)

The Sunmed disposable angio-closure pads is to assist in obtaining and maintaining hemostasis.

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------|--|
| | |

X | Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 5. 510(k) Summary

| 1. | Submitted by: | Sunny Medical Device (Shenzhen) Co., Ltd. |
|----|---------------------|-----------------------------------------------------------------------|
| | Registered Address: | 1/F and 401, Zhongtianxin Building B,<br>Longgang District, Shenzhen, |
| | | Guangdong, P.R. China 518172 |
| | Contact Address: | 11630 Wilkins Ave, APT # 104<br>Los Angeles, CA 90024<br>USA |
| | Telephone: | [phone] |
| | Fax: | [phone] |
| | Contact: | JamesQi Zhang, General Manager |
| | E-mail: | [e-mail] |
| | Date: | Mar 7, 2020 |

- 2. Proposed Device:

| Trade/Proprietary Name: | SunmedTM disposable angio-closure pads |
|-------------------------|----------------------------------------|
| Common/Usual Name: | disposable angio-closure pads |
| Classification: | II |
| ClassificationName: | Clamp, Vascular |
| Regulation Number: | 870.4450 |
| Product Code: | DXC |

- 3. Predicate Device:

| 510(k)<br>Number | Trade Name | Manufacture |
|------------------|-----------------------------------------------|-----------------|
| K062569 | Safeguard™ 24cm pressure<br>assisted dressing | Datascope Corp. |

{4}------------------------------------------------

## 4. Device description

disposable angio-closure pads is composed of compression bulb, The compression band and infusion mouth. Compression bulb is made from medical Polyurethane. Compression band is made from medical adhesive tape. Infusion mouth is made from medical Polycarbonate.

- 5. Intended Use
The Sunmed™ disposable angio-closure pads is to assist in obtaining and maintaining hemnostasis.

- 6. Technological Comparison to Predicate Device
The technological characteristics of the subject device, The Sunmed™ disposable angio-closure pads, are equivalent to the Safeguard™ 24cm pressure assisted dressing in terms of intended use, fundamental scientific technology, operating principle, sterility assurance level, and method of sterilization.

- 7. Summary of Non-Clinical Testing
The following tests were performed on the Sunmed™ angio-closure pads:

Biocompatibility Testing: Pyrogen Test Acute Systemic Toxicity Test(two kinds of solvent) Skin sensitization Test (two kinds of solvent) Intracutaneous Reactivity Test (two kinds of solvent) In Vitro Cytotoxicity Test Bacterial endotoxins test

Package Penetrate Testing Asepsis Testing Aging Testing EtO and ECH Residue Testing Bench Testing

- 8. Clinical Evaluation was not applicable.
- 9. Conclusions

Based on the information presented in this 510(k) premarket notification, the Sunmed™ disposable angio-closure pads is considered substantially equivalent to the Safeguard™ 24cm pressure assisted dressing.